Medicine · Health Sciences
11h-index8.9kcitations123works0.02yr avg
Accepting Students?
No reports yet. Know if this professor is taking students?
Research Topics
Diabetes Management and Research(32), Diabetes Treatment and Management(26), Diabetes, Cardiovascular Risks, and Lipoproteins(16), Diabetes and associated disorders(15), Pancreatic function and diabetes(13)
Publications123 total
Risk of anaemia with metformin use: A MASTERMIND study
Diabetic Medicine·2020
Risk factors for heart failure in the ACE trial population
Diabetologia·2019
Estimating cardiovascular risk and all-cause mortality in individuals with type 2 diabetes using the UKPDS Outcomes Model
Diabetologia·2019· 1 cited
Predicting risk for new-onset type 2 diabetes in Chinese people with coronary heart disease and impaired glucose tolerance
Diabetologia·2019
Apollo (University of Cambridge)·2018Open Access
The effect of lixisenatide on post-prandial blood glucose and glucagon in type 1 diabetes
Diabetologia·2018· 1 cited
Risk of cardiovascular disease in individuals with latent autoimmune diabetes of adults: results from the UKPDS
Diabetologia·2018
Oxford University Research Archive (ORA) (University of Oxford)·2018Open Access
Cardiovascular safety and efficacy of exenatide once-weekly in patients with moderate renal dysfunction in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL)
Diabetologia·2018
Oxford University Research Archive (ORA) (University of Oxford)·2018Open Access
Effect of Exenatide Once-Weekly on Clinical Outcomes in Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease: Insights From the EXSCEL Trial
Circulation·2017· 2 cited
Oxford University Research Archive (ORA) (University of Oxford)·2017Open Access
Are the cardiovascular risk reductions seen with empagliflozin in the EMPA-REG OUTCOME trial explained by conventional cardiovascular risk factors?
Oxford University Research Archive (ORA) (University of Oxford)·2017· 1 cited
Time to insulin in the Trial Evaluating Cardiovascular Outomes with Sitagliptin (TECOS)
Diabetologia·2017
Resource use and UK-perspective costs in patients with type 2 diabetes during the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)
Diabetologia·2017
Risk of anaemia with long-term metformin use in a community setting
Oxford University Research Archive (ORA) (University of Oxford)·2017
Development of an online risk calculator to predict durability of good glycaemic control with sulfonylurea and thiazolidinedione therapy: a MASTERMIND stratified medicine study
Diabetic Medicine·2017
Modelling incremental benefits on macro- and micro-vascular complications rates when targeting lower systolic blood pressure levels in type 2 diabetes
Diabetologia·2017
Sensing hypoglycaemia at an earlier stage using an integrated physiological multi-signal data fusion approach
Diabetic Medicine·2017
A calculator to predict durability of HbA(1c) response with DPP4 inhibitors, sulfonylureas and thiazolidinediones: a MASTERMIND precision medicine study
Diabetologia·2017
page 1 of 7Next →
Frequent Co-authors
R. C. Turner(13), Richard Stevens(7), Ruth L. Coleman(6), Irene Stratton(5), J Lévy(4), C A Cull(4), Matthews(3), C A Cull(3), Andrew T. Hattersley(3), B. Barrow(3), J Steemson(3), John B. Buse(3), Susan E. Manley(2), M. Angelyn Bethel(2), R M Califf(2), Andrew E. Clark(2), J. C. Moore(2), R. Jelfs(2), Harald Sourij(2), V Mayonwhite(2)